stars 1 stars 2 stars 3

Develop creative neurotechnology for improving the health and quality of life of individuals with neurological conditions. While our present focus is epilepsy, our vision extends to assisting with a multitude of neurological disorders. Epilepsy is a chronic disease characterized by seizures of enhanced and synchronous electrical activity in neuronal networks in the brain, affecting 1% of the world's population. Importantly, around 30% of the patients do not respond to current medications and their seizures cannot be predicted Our team developed novel data analysis and machine learning solutions that use non-invasive brain monitoring to forecast upcoming seizures an hour in advance. Our team's goal is turning epilepsy into a disorder that does not limit the ability of patients to enjoy common activities and is no longer life-threatening.

NeuroHelp Questions

Shay Ben-Sasson is the CEO of NeuroHelp.

9 people are employed at NeuroHelp.

Top NeuroHelp Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users